Official 2024 U.S. DOL Form 5500 summary for Anip Acquisitions D/b/a Ani Pharmaceuticals, INC. (Ani Pharmaceuticals, INC. 401(k) Plan · EIN 20-0808920 · PN 001): $44.04M net assets, 725 active participants, and $24.59 per $10,000 (24.59 bps).
| Plan Sponsor | Anip Acquisitions D/b/a Ani Pharmaceuticals, INC. |
|---|---|
| Filing Identifier | Ani Pharmaceuticals, INC. 401(k) Plan · EIN 20-0808920 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (MN) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $44.04M |
| Active Participants | 725 |
| Direct Admin Fee Rate | $24.59 per $10,000 (24.59 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Wells Fargo Clearing Services LLC |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($246,497, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI